YAEL HAYON
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
Protalix BioTherapeutics, Inc.
Filing Date
Source Excerpt
2021-09-30
Yael Hayon Consists of 40,553 shares of our common stock issuable upon exercise of outstanding options
Data sourced from SEC filings. Last updated: 2026-02-08